2. Non-A, Non-B hepatitis: A case report.
Anderson MG, Murray-Lyon IM, Coleman JC, McCaul TF, Bird RG,
Tovey G and Zuckerman AJ
Journal of Medical Virology 1982;9:217-229

3. Interpretation of liver function tests.
Anderson MG and Murray-Lyon IM
Maternal and Child Health 1984;9:52-6

4. Persistent lymphadenopathy in homosexual men; a clinical and
ultrastructural study.
Anderson MG, Dixey J, Key P, Ellis DS, Tovey G, McCaul TF,
Murray-Lyon IM, Gazzard B, Lawrence A, Evans B, Byrom N and
Zuckerman AJ.
Lancet 1984;i:880-2

5. Hepatitis B vaccine.
Anderson MG and Murray-Lyon IM
Postgraduate Doctor 1984;7:726-30

6. Intracytoplasmic inclusions in human hepatocytes in Non-A Non-B; an
ultrastructural study.
McCaul TF, Tovey G, Anderson MG, Murray-Lyon IM and
Zuckerman AJ
Journal of Medical Virology 1984;14:387-402

7. The importance of the hepatitis Be antigen in the management of chronic
hepatitis B infection.
Anderson MG and Murray-Lyon IM.
Gastroenterology in practice 1984;1:32-34

8. Liver Disease and Intensive Care.
Anderson MG and Murray-Lyon IM
In: Intensive Care. Ed. W Gerson. London, Heinmann, 1984.

9. Acquired immunodeficiency syndrome and Kaposi's sarcoma.
Muhlemann MF, Anderson MG, Murray-Lyon IM, Scott OL
Journal of the Royal Society of Medicine 1985;78:158-9

10. Alpha interferon improves interleukin 2 activity in hepatitis B virus related
chronic liver disease.
Saxena S, Nouri-Aria KT, Anderson MG, Williams R and Eddlestone ALWF
Journal of Hepatology 1985;1:385

11. The natural history of hepatitis B virus infection.
Anderson MG and Murray-Lyon IM
Gut 1985;26:848-60

12. Altered natural history of hepatitis B in homosexual males - a reflection of
altered immune responsiveness ?
Anderson MG, Eddlestone ALWF and Murray-Lyon IM
Journal of Medical Virology 1985;17:167-73

13. Early warning skin signs in persistent generalised lymphadenopathy & AIDS.
Muhlemann MF, Anderson MG, Paradinas FJ, Key PR,
Dawson SG, Evans B, Murray-Lyon IM and Cream JJ
British Journal of Dermatology 1986;114:419-24

14. Hepatitis B virus DNA in the hepatocyte. A series of 160 biopsies.
Harrison TJ, Anderson MG, Murray-Lyon IM and Zuckerman AJ
Journal of Hepatology 1986;2:1-10

15. Interleukin 2 activity in chronic liver disease and the effect of in-vitro alpha interferon.
Saxena S, Nouri-Aria KT, Anderson MG, Williams R and Eddlestone ALWF
Clinical and Experimental Immunology 1986;63:541-8

16. Trial of (+)- cyanidanol-3 in patients with hepatitis B chronic liver disease.
Keeling PW, Viola L, Anderson MG, Marigold JH, Macartney JC, Paradinas
FJ, Murray-Lyon IM and Thompson RP
Journal of the Royal Society of Medicine 1986;79:460-1

17. Prevention of chronic hepatitis B and antiviral therapy.
Anderson MG and Murray-Lyon IM
Current Opinion in Gastroenterology 1986;2:463-70

18. Strategy for lymph node biopsy in homosexual men suspected of having
LAV/HTLV-III related disease.
Scott HJ, Glynn MJ, Lane IF, Anderson MG, Theodorou NA,
Murray-Lyon IM and Reynolds KW
British Journal of Surgery 1986;73:186-7

19. A controlled trial of lymphoblastoid interferon (Wellferon) in chronic active
hepatitis B.
Anderson MG, Harrison TJ, Alexander G, Zuckerman AJ, Murray-Lyon IM
Journal of Hepatology 1986;3:S225-7

20. Pneumonia in AIDS patients.
Anderson MG
In: Proceedings IX International Congress of Infectious and Parasitic
Diseases, Munich 1986, Vol III.
Ed. Marget W,Lang W and Gabler-Sandberger E.
p.156-60. Medizrn Verlag Munchen, Munich 1986.

21. Suramin treatment for chronic active hepatitis B - toxic and ineffective.
Loke R, Anderson MG, Coleman JC, Tsiquaye K, Zuckerman AJ
and Murray-Lyon IM
Journal of Medical Virology 1987;21:97-9

22. Randomised controlled trial of lymphoblastoid interferon for chronic active
hepatitis B.
Anderson MG, Harrison TJ, Alexander G, Zuckerman AJ, Murray-Lyon IM
Gut 1987;28:619-22

23. Use of Karpas HIV cell test to detect antibodies to HIV-2.
Karpas A, Hayhoe FGJ, Hill F, Anderson MG, Tenant-Flowers M, Howard L
and Oates JK.
Lancet 1987;ii:132-3

24. Differential effect of alpha-interferons on CD4- and CD8-positive
lymphocytes in chronic hepatitis B virus carriers.
Nouri-Aria KT, Alexander GJM, Magrin S, Anderson MG, Eddleston ALWF
and Williams R
Journal of Hepatology 1988;7:1-6

25. Abnormal T cell activation in chronic hepatitis B viral infection: a
consequence of monocyte dysfunction?
Nouri-Aria KT, Magrin S, Alexander GJM, Anderson MG, Williams R and
Eddleston ALWF
Immunology 1988;64:733-8

26. Aids in ICU's: Outcome
Dean R, Kimberley APS, Anderson MG and Soni N
Anaesthesia 1988;43:150-1

27. Reduced immunogenicity of recombinant yeast Hepatitis B vaccine in HIV
antibody positive male homosexuals.
Loke R, Anderson MG, Murray-Lyon IM, Evans B, Coleman J, Tsiquaye K
and Zuckerman AJ
In: Viral Hepatitis and Liver Disease. Ed. Zuckerman AJ.
Alan Liss, New York. 1988

28. Hepatitis.
Anderson MG and Coleman JC
In: Sexually Transmitted Diseases. Ed. Csonka G, Oates JK
Bailliere Tindall, Eastbourne, UK. 1990

29. The Acquired Immune Deficiency Syndrome.
Anderson MG and Gazzard BG
In: Sexually transmitted Diseases. Ed. Csonka G, Oates JK
Bailliere Tindall, Eastbourne, UK. 1990

30. Zidovudine
Anderson MG
In: Therapeutic Drugs: A Clinical Pharmacopoeia. Ed.
Dollery C. Churchill Livingstone 1992

31. Pontine myelinolysis presenting with acute Parkinsonism as a sequel of
corrected hyponatraemia.
Tinker R, Anderson MG, Anand P and Harding A
Journal of Neurology, Neurosurgery and Psychiatry 1990;53:87

32. Gastrointestinal manifestations of AIDS in the third world.
Anderson MG
In: Clinical Gastroenterology: Ed. Gazzard BG. Bailliere
Tindall, Eastbourne, UK. 1990

33. Safety of alcohol after viral hepatitis.
Tozun N, Forbes A, Anderson MG and Murray-Lyon IM
Lancet 1991;337:1079-1080

34. Mesalazine induced interstitial nephritis.
Thuluvath PJ, Ninkovic M, Calam J and Anderson MG
Gut 1994; 35:1493-1496

35. Endoscopic balloon dilatation versus endoscopic sphincterotomy for the
removal of bile duct stones : a prospective randomised trial.
Vlavianos P, Chopra K, Mandalia S, Anderson M, Thompson T, Westaby D.
Gut 2003:52:1165-1169